Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).
Short-term activity ratio | Description | The company |
---|---|---|
Inventory turnover | An activity ratio calculated as cost of goods sold divided by inventory. | Baxter International Inc. inventory turnover ratio deteriorated from Q4 2015 to Q1 2016 but then improved from Q1 2016 to Q2 2016 exceeding Q4 2015 level. |
Receivables turnover | An activity ratio equal to revenue divided by receivables. | Baxter International Inc. receivables turnover ratio deteriorated from Q4 2015 to Q1 2016 but then slightly improved from Q1 2016 to Q2 2016. |
Working capital turnover | An activity ratio calculated as revenue divided by working capital. | Baxter International Inc. working capital turnover ratio improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016. |
Short-term activity ratio | Description | The company |
---|---|---|
Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Baxter International Inc. number of days of inventory outstanding deteriorated from Q4 2015 to Q1 2016 but then improved from Q1 2016 to Q2 2016 exceeding Q4 2015 level. |
Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnover. | Baxter International Inc. number of days of receivables outstanding deteriorated from Q4 2015 to Q1 2016 but then slightly improved from Q1 2016 to Q2 2016. |
Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Baxter International Inc. operating cycle deteriorated from Q4 2015 to Q1 2016 but then improved from Q1 2016 to Q2 2016 exceeding Q4 2015 level. |
Inventory Turnover
Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
Cost of sales | 1,613) | 1,410) | 1,531) | 1,453) | 1,454) | 1,384) | 2,248) | 2,124) | 2,185) | 1,957) | 2,414) | 1,828) | 1,730) | 1,692) | 1,848) | 1,667) | 1,700) | 1,674) | 1,829) | 1,708) | 1,701) | 1,609) | |||||||
Inventories | 1,591) | 1,682) | 1,604) | 1,696) | 3,842) | 3,501) | 3,559) | 3,704) | 3,836) | 3,748) | 3,499) | 3,581) | 3,069) | 2,963) | 2,803) | 2,831) | 2,730) | 2,737) | 2,628) | 2,621) | 2,648) | 2,517) | |||||||
Short-term Activity Ratio | |||||||||||||||||||||||||||||
Inventory turnover1 | 3.78 | 3.48 | 3.63 | 3.86 | 1.88 | 2.27 | 2.39 | 2.34 | 2.19 | 2.12 | 2.19 | 1.98 | 2.26 | 2.33 | 2.46 | 2.43 | 2.53 | 2.53 | 2.61 | — | — | — | |||||||
Benchmarks | |||||||||||||||||||||||||||||
Inventory Turnover, Competitors2 | |||||||||||||||||||||||||||||
Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).
1 Q2 2016 Calculation
Inventory turnover
= (Cost of salesQ2 2016
+ Cost of salesQ1 2016
+ Cost of salesQ4 2015
+ Cost of salesQ3 2015)
÷ Inventories
= (1,613 + 1,410 + 1,531 + 1,453)
÷ 1,591 = 3.78
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Inventory turnover | An activity ratio calculated as cost of goods sold divided by inventory. | Baxter International Inc. inventory turnover ratio deteriorated from Q4 2015 to Q1 2016 but then improved from Q1 2016 to Q2 2016 exceeding Q4 2015 level. |
Receivables Turnover
Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
Net sales | 2,585) | 2,375) | 2,603) | 2,487) | 2,475) | 2,403) | 4,472) | 4,197) | 4,154) | 3,848) | 4,368) | 3,774) | 3,669) | 3,448) | 3,753) | 3,477) | 3,572) | 3,388) | 3,594) | 3,479) | 3,536) | 3,284) | |||||||
Accounts and other current receivables, net | 1,813) | 1,830) | 1,731) | 1,772) | 2,852) | 2,599) | 2,803) | 2,842) | 2,914) | 2,708) | 2,911) | 2,766) | 2,342) | 2,319) | 2,425) | 2,324) | 2,225) | 2,341) | 2,420) | 2,347) | 2,491) | 2,399) | |||||||
Short-term Activity Ratio | |||||||||||||||||||||||||||||
Receivables turnover1 | 5.54 | 5.43 | 5.76 | 6.68 | 4.75 | 5.86 | 5.95 | 5.83 | 5.54 | 5.78 | 5.24 | 5.29 | 6.13 | 6.14 | 5.85 | 6.04 | 6.31 | 5.98 | 5.74 | — | — | — | |||||||
Benchmarks | |||||||||||||||||||||||||||||
Receivables Turnover, Competitors2 | |||||||||||||||||||||||||||||
Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).
1 Q2 2016 Calculation
Receivables turnover
= (Net salesQ2 2016
+ Net salesQ1 2016
+ Net salesQ4 2015
+ Net salesQ3 2015)
÷ Accounts and other current receivables, net
= (2,585 + 2,375 + 2,603 + 2,487)
÷ 1,813 = 5.54
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Receivables turnover | An activity ratio equal to revenue divided by receivables. | Baxter International Inc. receivables turnover ratio deteriorated from Q4 2015 to Q1 2016 but then slightly improved from Q1 2016 to Q2 2016. |
Working Capital Turnover
Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
Current assets | 6,823) | 8,017) | 11,796) | 11,138) | 14,497) | 9,734) | 10,351) | 9,631) | 9,487) | 9,388) | 10,004) | 9,597) | 12,185) | 8,814) | 9,260) | 9,105) | 8,048) | 8,117) | 8,650) | 8,002) | 7,809) | 7,761) | |||||||
Less: Current liabilities | 3,723) | 3,823) | 5,750) | 5,981) | 6,312) | 6,074) | 6,042) | 5,990) | 5,795) | 5,645) | 5,906) | 4,996) | 4,516) | 4,778) | 4,759) | 4,458) | 4,870) | 4,857) | 4,857) | 4,165) | 4,031) | 3,889) | |||||||
Working capital | 3,100) | 4,194) | 6,046) | 5,157) | 8,185) | 3,660) | 4,309) | 3,641) | 3,692) | 3,743) | 4,098) | 4,601) | 7,669) | 4,036) | 4,501) | 4,647) | 3,178) | 3,260) | 3,793) | 3,837) | 3,778) | 3,872) | |||||||
Net sales | 2,585) | 2,375) | 2,603) | 2,487) | 2,475) | 2,403) | 4,472) | 4,197) | 4,154) | 3,848) | 4,368) | 3,774) | 3,669) | 3,448) | 3,753) | 3,477) | 3,572) | 3,388) | 3,594) | 3,479) | 3,536) | 3,284) | |||||||
Short-term Activity Ratio | |||||||||||||||||||||||||||||
Working capital turnover1 | 3.24 | 2.37 | 1.65 | 2.30 | 1.66 | 4.16 | 3.87 | 4.55 | 4.37 | 4.18 | 3.72 | 3.18 | 1.87 | 3.53 | 3.15 | 3.02 | 4.42 | 4.29 | 3.66 | — | — | — | |||||||
Benchmarks | |||||||||||||||||||||||||||||
Working Capital Turnover, Competitors2 | |||||||||||||||||||||||||||||
Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).
1 Q2 2016 Calculation
Working capital turnover
= (Net salesQ2 2016
+ Net salesQ1 2016
+ Net salesQ4 2015
+ Net salesQ3 2015)
÷ Working capital
= (2,585 + 2,375 + 2,603 + 2,487)
÷ 3,100 = 3.24
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Working capital turnover | An activity ratio calculated as revenue divided by working capital. | Baxter International Inc. working capital turnover ratio improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016. |
Average Inventory Processing Period
Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data | |||||||||||||||||||||||||||||
Inventory turnover | 3.78 | 3.48 | 3.63 | 3.86 | 1.88 | 2.27 | 2.39 | 2.34 | 2.19 | 2.12 | 2.19 | 1.98 | 2.26 | 2.33 | 2.46 | 2.43 | 2.53 | 2.53 | 2.61 | — | — | — | |||||||
Short-term Activity Ratio (no. days) | |||||||||||||||||||||||||||||
Average inventory processing period1 | 97 | 105 | 101 | 95 | 194 | 161 | 153 | 156 | 167 | 173 | 167 | 184 | 161 | 157 | 149 | 150 | 144 | 145 | 140 | — | — | — | |||||||
Benchmarks (no. days) | |||||||||||||||||||||||||||||
Average Inventory Processing Period, Competitors2 | |||||||||||||||||||||||||||||
Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).
1 Q2 2016 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 3.78 = 97
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Baxter International Inc. number of days of inventory outstanding deteriorated from Q4 2015 to Q1 2016 but then improved from Q1 2016 to Q2 2016 exceeding Q4 2015 level. |
Average Receivable Collection Period
Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data | |||||||||||||||||||||||||||||
Receivables turnover | 5.54 | 5.43 | 5.76 | 6.68 | 4.75 | 5.86 | 5.95 | 5.83 | 5.54 | 5.78 | 5.24 | 5.29 | 6.13 | 6.14 | 5.85 | 6.04 | 6.31 | 5.98 | 5.74 | — | — | — | |||||||
Short-term Activity Ratio (no. days) | |||||||||||||||||||||||||||||
Average receivable collection period1 | 66 | 67 | 63 | 55 | 77 | 62 | 61 | 63 | 66 | 63 | 70 | 69 | 60 | 59 | 62 | 60 | 58 | 61 | 64 | — | — | — | |||||||
Benchmarks (no. days) | |||||||||||||||||||||||||||||
Average Receivable Collection Period, Competitors2 | |||||||||||||||||||||||||||||
Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).
1 Q2 2016 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 5.54 = 66
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnover. | Baxter International Inc. number of days of receivables outstanding deteriorated from Q4 2015 to Q1 2016 but then slightly improved from Q1 2016 to Q2 2016. |
Operating Cycle
Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data | |||||||||||||||||||||||||||||
Average inventory processing period | 97 | 105 | 101 | 95 | 194 | 161 | 153 | 156 | 167 | 173 | 167 | 184 | 161 | 157 | 149 | 150 | 144 | 145 | 140 | — | — | — | |||||||
Average receivable collection period | 66 | 67 | 63 | 55 | 77 | 62 | 61 | 63 | 66 | 63 | 70 | 69 | 60 | 59 | 62 | 60 | 58 | 61 | 64 | — | — | — | |||||||
Short-term Activity Ratio | |||||||||||||||||||||||||||||
Operating cycle1 | 163 | 172 | 164 | 150 | 271 | 223 | 214 | 219 | 233 | 236 | 237 | 253 | 221 | 216 | 211 | 210 | 202 | 206 | 204 | — | — | — | |||||||
Benchmarks | |||||||||||||||||||||||||||||
Operating Cycle, Competitors2 | |||||||||||||||||||||||||||||
Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Medtronic PLC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).
1 Q2 2016 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 97 + 66 = 163
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Baxter International Inc. operating cycle deteriorated from Q4 2015 to Q1 2016 but then improved from Q1 2016 to Q2 2016 exceeding Q4 2015 level. |